Mark Cuban's Online Pharmacy Partners With Coherus Biosciences for Humira Biosimilar

The Mark Cuban Cost Plus Drug Company, an online pharmacy dedicated to increasing access to lower-cost prescriptions, is partnering with Coherus Biosciences to distribute Yusimry, a biosimilar referencing Humira. It’s the first time the pharmacy has added a biosimilar to its list of drugs.

Related Keywords

Cuba ,Dallas ,Texas ,United States ,Cuban ,Alex Oshmyansky ,Coherus Biosciences ,Denny Lanfear ,Team Cuban Card ,Association For Accessible Medicines Access ,Mark Cuban Cost Plus Drug Company ,Dallas Mavericks ,Mark Cuban ,Cost Plus Drugs ,Cuban Cost Plus Drug Company ,Cost Plus ,Plus Drugs ,Adding Yusimry ,Accessible Medicines ,Biosimilars ,Coherus ,Humira ,Adalimumab ,